Review of the treatment of acute coronary syndrome in elderly patients

References

• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineJ Am Coll Cardiol2007814507e1e15717692738
   PubMed Web of Science ®Google Scholar
• AntmanEMAnbeDTArmstrongPWACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)J Am Coll Cardiol20044467171915358045
   PubMedGoogle Scholar
• AntmanEMHandMArmstrongPW2007Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing CommitteeCirculation2008115117229632918071078
   PubMed Web of Science ®Google Scholar
• ThygesenKAlpertJSWhiteHDUniversal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionEur Heart J20071028202525253817951287
   PubMed Web of Science ®Google Scholar
• DeWoodMASporesJNotskeRPrevalence of total coronary occlusion during the early hours of transmural myocardial infarctionN Engl J Med19801016303168979027412821
   PubMed Web of Science ®Google Scholar
• DeWoodMASporesJHensleyGRCoronary arteriographic findings in acute transmural myocardial infarctionCirculation1983868(2 Pt 2):I39496602670
   PubMed Web of Science ®Google Scholar
• LiebsonPRKleinLWThe non-Q wave myocardial infarction revisited: 10 years laterProg Cardiovasc Dis1997 Mar–Apr3953994449122424
   PubMed Web of Science ®Google Scholar
• Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI III A) TrialCirculation1993187138528419023
   PubMed Web of Science ®Google Scholar
• KerenskyRAWadeMDeedwaniaPRevisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratoryJ Am Coll Cardiol2002513991456146311985907
   PubMed Web of Science ®Google Scholar
• WongGCMorrowDAMurphySElevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial InfarctionCirculation200279106220220712105159
   PubMed Web of Science ®Google Scholar
• JangIKGoldHKZiskindAADifferential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysisCirculation198947949209282494006
   PubMed Web of Science ®Google Scholar
• MizunoKSatomuraKMiyamotoAAngioscopic evaluation of coronary-artery thrombi in acute coronary syndromesN Engl J Med199213032652872911728732
   PubMed Web of Science ®Google Scholar
• AlexanderKPRoeMTChenAYCRUSADE Investigators. Evolution in cardiovascular care for elderly patients with non-ST–segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement InitiativeJ Am Coll Cardiol2005461479148716226171
   PubMed Web of Science ®Google Scholar
• GoldbergRJMcCormickDGurwitzJHAge-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975–1995)Am J Cardiol19981218211131113179856911
   PubMed Web of Science ®Google Scholar
• RogerVLJacobsenSJWestonSATrends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994Ann Intern Med200235136534134811874305
   PubMed Web of Science ®Google Scholar
• The future of CVDMackayJMensahGThe Atlas of Heart Disease and StrokeGeneva, SwitzerlandWorld Health Organization20047475 Available at: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_25_future.pdf Accessed April 19, 2008.
   Google Scholar
• CDCPublic health and aging: trends in aging: United States and worldwideMMWR20035210110612645839
   PubMedGoogle Scholar
• BriegerDEagleKAGoodmanSGGRACE Investigators. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary EventsChest200412646146915302732
   PubMed Web of Science ®Google Scholar
• BayerAJChadhaJSFaragRRChanging presentation of myocardial infarction with increasing old ageJ Am Geriatr Soc198643442632663950299
   PubMed Web of Science ®Google Scholar
• CantoJGShlipakMGRogersWJPrevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest painJAMA20002833223322910866870
   PubMed Web of Science ®Google Scholar
• AlexanderKPNewbyLKCannonCPAcute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyCirculation2007115254917502590
   PubMed Web of Science ®Google Scholar
• AlexanderKPNewbyLKCannonCPAcute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyCirculation2007515115192570258917502591
   PubMed Web of Science ®Google Scholar
• CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
   PubMed Web of Science ®Google Scholar
• The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy InvestigatorsA clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarctionN Engl J Med1997336162116289173270
   PubMed Web of Science ®Google Scholar
• ZijlstraFPatelAJonesMClinical characteristics and outcome of patients with early (<2 h), intermediate (2–4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionEur Heart J20022355011922645
   PubMed Web of Science ®Google Scholar
• BergerAKSchulmanKAGershBJPrimary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patientsJAMA199928234110432031
   PubMed Web of Science ®Google Scholar
• BergerAKRadfordMJWangYThrombolytic therapy in older patientsJ Am Coll Cardiol20003636610933344
   PubMed Web of Science ®Google Scholar
• StoneGWGrinesCLCoxDAComparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarctionN Engl J Med200234695711919304
   PubMed Web of Science ®Google Scholar
• GuagliumiGStoneGWCoxDAOutcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialCirculation2004110159815353506
   PubMed Web of Science ®Google Scholar
• de BoerMJOttervangerJPvan’t HofAWReperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapyJ Am Coll Cardiol200239172312039482
   PubMed Web of Science ®Google Scholar
• StenestrandUWallentinLFibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohortArch Intern Med200316396597112719207
   PubMedGoogle Scholar
• BergerAKRadfordMJWangYKrumholzHMThrombolytic therapy in older patientsJ Am Coll Cardiol20003636637410933344
   PubMed Web of Science ®Google Scholar
• CollinsROptimizing thrombolytic therapy of acute myocardial infarction: Age is not a contraindicationCirculation199184II230
   Google Scholar
• ThiemannDRCoreshJSchulmanSPLack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 yearsCirculation2000101223910811589
   PubMed Web of Science ®Google Scholar
• NallamothuBKBatesERTimes to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysisCirculation200511176115699253
   PubMed Web of Science ®Google Scholar
• Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic InvestigatorsLancet199935471610475182
   PubMed Web of Science ®Google Scholar
• Van de WerfFBarronHVArmstrongPWIncidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAEur Heart J200122225311728145
   PubMed Web of Science ®Google Scholar
• BrassLMLichtmanJHWangYIntracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction. Results from the Cooperative Cardiovascular ProjectStroke200031180210926938
   PubMed Web of Science ®Google Scholar
• GurwitzJHGoreJMGoldbergRJRisk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarctionAnn Intern Med19981295979786806
   PubMed Web of Science ®Google Scholar
• GoreJMGrangerCBSimoonsMLStroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary ArteriesCirculation19959228117586246
   PubMed Web of Science ®Google Scholar
• BachRGCannonCPWeintraubWSThe effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesAnn Intern Med200483141318619515289215
   PubMed Web of Science ®Google Scholar
• AntmanEMCohenMBerninkPJThe TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision makingJAMA200028483584210938172
   PubMed Web of Science ®Google Scholar
• EagleKALimMJDabbousOHA validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryJAMA20042912727273315187054
   PubMed Web of Science ®Google Scholar
• KingSBIIISmithSCJrHirshfeldJWJr2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelinesJ Am Coll Cardiol200811551217220918191745
   PubMed Web of Science ®Google Scholar
• SagarKASmythMRA comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatographyJ Pharm Biomed Anal19992138339210703994
   PubMed Web of Science ®Google Scholar
• EllisSGColomboAGrubeEIncidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 yearsJ Am Coll Cardiol2007313491010431051 Epub 2007 Feb 26.17349883
   PubMed Web of Science ®Google Scholar
• RoironCSanchezPBouzamondoADrug eluting stents: an updated meta-analysis of randomised controlled trialsHeart20065925641649 Epub 2005 Oct 10.16216853
   PubMed Web of Science ®Google Scholar
• KastratiADibraAEberleSSirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trialsJAMA2005817294781982516106007
   PubMed Web of Science ®Google Scholar
• BavryAAKumbhaniDJHeltonTJLate thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trialsAm J Med200612119121056106117145250
   PubMed Web of Science ®Google Scholar
• MauriLHsiehWHMassaroJMStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med2007383561010201029 Epub 2007 Feb 12.17296821
   PubMed Web of Science ®Google Scholar
• StoneGWMosesJWEllisSGSafety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsN Engl J Med200738356109981008 Epub 2007 Feb 12.17296824
   PubMed Web of Science ®Google Scholar
• SpauldingCDaemenJBoersmaEA pooled analysis of data comparing sirolimus-eluting stents with bare-metal stentsN Engl J Med20073835610989997 Epub 2007 Feb 12.17296825
   PubMed Web of Science ®Google Scholar
• ChenZMJiangLXChenYPCOMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialLancet20053661607162116271642
   PubMed Web of Science ®Google Scholar
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative GroupISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionLancet19953456696857661937
   PubMed Web of Science ®Google Scholar
• Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto MiocardiocoSix-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after myocardial infarction: the GISSI-3 TrialJ Am Coll Cardiol1996273373448557903
   PubMed Web of Science ®Google Scholar
• The Acute Infarction Ramipril Efficacy (AIRE) Study InvestigatorsEffect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failureLancet19933428218288104270
   PubMed Web of Science ®Google Scholar
• DicksteinKKjekshusJOPTIMAAL Steering Committee of the OPTIMAAL Study GroupEffects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial: Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist LosartanLancet200236075276012241832
   PubMed Web of Science ®Google Scholar
• WhiteHDAylwardPEHuangYVALIANT InvestigatorsMortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Circulation20051123391339916301343
   PubMed Web of Science ®Google Scholar
• PittBRemmeWZannadFEplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarctionN Engl J Med2003433481413091321 Epub 2003 Mar 31.12668699
   PubMed Web of Science ®Google Scholar
• LaRosaJCGrundySMWatersDDIntensive lipid lowering with atorvastatin in patients with stable coronary diseaseN Engl J Med2005473521414251435 Epub 2005 Mar 8.15755765
   PubMed Web of Science ®Google Scholar
• WengerNKLewisSJWeltyFKBeneficial effects of aggressive LDL cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) studyHeart20071210
   Web of Science ®Google Scholar
• CannonCPBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med2004483501514951504 Epub 2004 Mar 8.15007110
   PubMed Web of Science ®Google Scholar
• SchwartzGGOlssonAGEzekowitzMDEffects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialJAMA200144285131711171811277825
   PubMed Web of Science ®Google Scholar
• WengerNKFroelicherESSmithLKCardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood InstituteClin Pract Guidel Quick Ref Guide Clin19951238595435
   PubMedGoogle Scholar
• BaladyGJAdesPAComossPCore components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing GroupCirculation20001021069107310961975
   PubMed Web of Science ®Google Scholar
• WittBJJacobsenSJWestonSACardiac rehabilitation after myocardial infarction in the communityJ Am Coll Cardiol20044498899615337208
   PubMed Web of Science ®Google Scholar
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell‘Infarto miocardicoLancet199987354917744745510465168
   PubMed Web of Science ®Google Scholar
• MarchioliRBarziFBombaEEarly protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell‘Infarto Miocardico (GISSI)-PrevenzioneCirculation2002423105161897190311997274
   PubMed Web of Science ®Google Scholar
• EagleKAGuytonRADavidoffRACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery)Circulation200410511014e340e43715466654
   PubMedGoogle Scholar
• HannanELBurkeJEffect of age on mortality in coronary artery bypass surgery in New York, 1991–1992Am Heart J19941281184917985600
   PubMed Web of Science ®Google Scholar
• IvanovJWeiselRDDavidTENaylorCDFifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgeryCirculation1998976736809495303
   PubMed Web of Science ®Google Scholar
• HochmanJSSleeperLAWhiteHDfor the SHOCK InvestigatorsShould We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shockJAMA200128519019211176812
   PubMed Web of Science ®Google Scholar
• NagpalADBhatnagarGCutraraCAEarly outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenariansCan J Cardiol20062284985316957802
   PubMed Web of Science ®Google Scholar
• AthanasiouTAl-RuzzehSKumarPOff-pump myocardial revascularization is associated with less incidence of stroke in elderly patientsAnn Thorac Surg20047774575314759484
   PubMed Web of Science ®Google Scholar
• PanesarSSAthanasiouTNairSEarly outcomes in the elderly: a metaanalysis of 4921 patients undergoing coronary artery bypass grafting – comparison between off-pump and on-pump techniquesHeart2006921808181616775087
   PubMed Web of Science ®Google Scholar